Novartis Investigative Site

Mexicali, Baja California Norte 21200

0 studies enrolling now · 2 studies all time

What they study most

IgA Nephropathy, Lupus Nephritis

Studies at this site

• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed
• Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis — Stopped early